The role of radiotherapy in the management of prostate cancer
Bernier, J.
Revue Medicale Suisse 3(114): 1472-1474
2007
ISSN/ISBN: 1660-9379 PMID: 17639669 Document Number: 611004
Document emailed within 1 workday
Related Documents
Soffen, E.M.; Greenberg, A.; Baumann, J.; Corn, B.W. 1997: The role of strontium-89 systemic radiotherapy in the management of osseous metastases from prostate cancer Techniques in Urology 3(2): 76-80Herr, H.W. 1991: The role of radiotherapy in locally limited prostate cancer Der Urologe. Ausg. a 30(6): 413-416
Baker, B.R.; Mohiuddin, J.J.; Chen, R.C. 2015: The role of radiotherapy in node-positive prostate cancer Oncology 29(2): 108-114; 116
Lukka, H. 2002: Prostate cancer: risk categories and role of hormones and radiotherapy Canadian Journal of Urology 9(Suppl 1): 26-29
Kirby, R. 2016: The role of PSA in detection and management of prostate cancer Practitioner 260(1792): 17-21; 3
Wong, R.; Thomas, G.; Cummings, B.; Froud, P.; Shelley, W.; Withers, R.H.; Williams, I.J. 1996: The role of radiotherapy in the management of pelvic recurrence of rectal cancer Canadian Journal of Oncology 6(Suppl 1): 39-47
González-Del-Alba Baamonde, A.án.; Sevillano Fernández, E. 2018: The role of corticoids in the management of advanced prostate cancer Archivos Espanoles de Urologia 71(3): 281-287
Saad, F.; Chi, K.; Fleshner, N. 2004: The role of bisphosphonates in the management of bone metastases in prostate cancer Canadian Journal of Urology 11(5): 2376-2382
Stock, R.G.; Ferrari, A.C.; Stone, N.N. 1998: Does pelvic irradiation play a role in the management of prostate cancer? Oncology 12(10): 1467-1472; Discussion 1472: 1475-1476
Odaka, M.; Ryu, M.; Usui, S.; Hirasawa, H.; Asano, T.; Yamamoto, Y.; Nagashima, T.; Sato, H. 1984: The role of radiotherapy in the management of cancer of digestive organs: the liver, bile tract and pancreas Nihon Geka Gakkai Zasshi 85(9): 1067-1071
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Allain, Y.M.; Bolla, M.; Brune, D.; Castelain, B.; Cellier, P.; Cuillere, J.C.; Douchez, J.; Geslin, J.; Hay, M.; Heintz, J. 1987: Prostate cancer: results of radiotherapy in French cancer institutes Progress in Clinical and Biological Research 243b: 121-139
Tkachev, S.I.; Matveev, V.B.; Trofimova, O.P.; Nazarenko, A.V.; Pylova, I.V.; Priamikova, I.I. 2010: Conformal radiotherapy for prostate cancer Voprosy Onkologii 56(2): 215-219
Dana, M.; Koskas, Y. 1974: Problems in radiotherapy of cancer of the prostate Journal de Radiologie d'Electrologie et de Medecine Nucleaire 55(11): 806-810
Bostwick, D.G. 1994: Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer American Journal of Clinical Pathology 102(4 Suppl 1): S31-S37
Hardeman, S.W.; Wake, R.W.; Soloway, M.S. 1989: Two new techniques for evaluating prostate cancer. The role of prostate-specific antigen and transrectal ultrasound Postgraduate Medicine 86(2): 197-8 201 204 Passim
Topuzov, M.E. 2007: Role of density of prostate-specific antigen transitory zone in early diagnosis of prostate cancer Voprosy Onkologii 53(3): 295-297
Benderli Cihan, Y. 2018: Role of mTOR signaling pathway proteins and proteins influencing mTOR pathway in resistance to radiotherapy in prostate cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 23(6): 1931-1932
Mayer, F.J.; Crawford, E.D. 1994: The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy Urologic Clinics of North America 21(4): 707-715
Rentsch, C.A.; Aebersold, D.M.; Merz, V.; Studer, U.E. 2005: Cancer of the prostate: importance of androgen deprivation and radiotherapy Revue Medicale Suisse 1(19): 1303-1306